16-46689167-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_018206.6(VPS35):​c.-34G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00125 in 1,603,544 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 15 hom. )

Consequence

VPS35
NM_018206.6 5_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.355

Publications

6 publications found
Variant links:
Genes affected
VPS35 (HGNC:13487): (VPS35 retromer complex component) This gene belongs to a group of vacuolar protein sorting (VPS) genes. The encoded protein is a component of a large multimeric complex, termed the retromer complex, involved in retrograde transport of proteins from endosomes to the trans-Golgi network. The close structural similarity between the yeast and human proteins that make up this complex suggests a similarity in function. Expression studies in yeast and mammalian cells indicate that this protein interacts directly with VPS35, which serves as the core of the retromer complex. [provided by RefSeq, Jul 2008]
VPS35 Gene-Disease associations (from GenCC):
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Parkinson disease 17
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • hereditary late onset Parkinson disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intellectual disability
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 16-46689167-C-T is Benign according to our data. Variant chr16-46689167-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 319298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00158 (240/152336) while in subpopulation EAS AF = 0.0274 (142/5182). AF 95% confidence interval is 0.0237. There are 4 homozygotes in GnomAd4. There are 120 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VPS35NM_018206.6 linkc.-34G>A 5_prime_UTR_variant Exon 1 of 17 ENST00000299138.12 NP_060676.2 Q96QK1
VPS35XM_011523227.4 linkc.-938G>A 5_prime_UTR_variant Exon 1 of 17 XP_011521529.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VPS35ENST00000299138.12 linkc.-34G>A 5_prime_UTR_variant Exon 1 of 17 1 NM_018206.6 ENSP00000299138.7 Q96QK1

Frequencies

GnomAD3 genomes
AF:
0.00156
AC:
238
AN:
152218
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.0273
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00141
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000514
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00328
AC:
725
AN:
220946
AF XY:
0.00310
show subpopulations
Gnomad AFR exome
AF:
0.0000750
Gnomad AMR exome
AF:
0.00211
Gnomad ASJ exome
AF:
0.00108
Gnomad EAS exome
AF:
0.0295
Gnomad FIN exome
AF:
0.00152
Gnomad NFE exome
AF:
0.000646
Gnomad OTH exome
AF:
0.00313
GnomAD4 exome
AF:
0.00122
AC:
1766
AN:
1451208
Hom.:
15
Cov.:
31
AF XY:
0.00117
AC XY:
843
AN XY:
720912
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33354
American (AMR)
AF:
0.00224
AC:
98
AN:
43660
Ashkenazi Jewish (ASJ)
AF:
0.00101
AC:
26
AN:
25802
East Asian (EAS)
AF:
0.0238
AC:
933
AN:
39140
South Asian (SAS)
AF:
0.00135
AC:
114
AN:
84396
European-Finnish (FIN)
AF:
0.00192
AC:
98
AN:
51050
Middle Eastern (MID)
AF:
0.000351
AC:
2
AN:
5696
European-Non Finnish (NFE)
AF:
0.000242
AC:
268
AN:
1108168
Other (OTH)
AF:
0.00369
AC:
221
AN:
59942
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
107
214
321
428
535
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00158
AC:
240
AN:
152336
Hom.:
4
Cov.:
33
AF XY:
0.00161
AC XY:
120
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41582
American (AMR)
AF:
0.00189
AC:
29
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.0274
AC:
142
AN:
5182
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4828
European-Finnish (FIN)
AF:
0.00141
AC:
15
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000515
AC:
35
AN:
68024
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000879
Hom.:
1
Bravo
AF:
0.00210
Asia WGS
AF:
0.00982
AC:
34
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Meier-Gorlin syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Parkinson disease 17 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
14
DANN
Benign
0.89
PhyloP100
-0.35
PromoterAI
-0.45
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3743928; hg19: chr16-46723079; API